Literature DB >> 22658985

Cancer associated human papillomaviruses.

Margaret E McLaughlin-Drubin1, Jordan Meyers, Karl Munger.   

Abstract

A small group of human papillomaviruses (HPVs) cause almost all cervical carcinoma and a significant percentage of other anogenital tract and oral carcinoma. Another group of HPVs causes non-melanoma skin cancers in genetically predisposed or immune suppressed patients upon UV exposure. HPV genome replication requires the host cell's DNA synthesis machinery and HPVs encode proteins that maintain differentiated epithelial cells in a replication competent state. The resulting rewiring of cellular signal transduction circuits triggers several innate cellular tumor suppressor responses that HPVs need to inactivate in order to establish persistent and/or productive infections. This review emphasizes this interplay between virus and the infected host cells and points out biological similarities and differences between different groups of HPVs.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658985      PMCID: PMC3422426          DOI: 10.1016/j.coviro.2012.05.004

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  50 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner.

Authors:  Sun Gwan Hwang; Daeyoup Lee; Jiyun Kim; Taegun Seo; Joonho Choe
Journal:  J Biol Chem       Date:  2001-11-16       Impact factor: 5.157

3.  Genomic analysis of the first laboratory-mouse papillomavirus.

Authors:  Joongho Joh; A Bennett Jenson; William King; Mary Proctor; Arvind Ingle; John P Sundberg; Shin-je Ghim
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

4.  Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions.

Authors:  Wei Feng; Xiuzhen Duan; Jinsong Liu; Jianguo Xiao; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

5.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

Authors:  W Zwerschke; S Mazurek; P Massimi; L Banks; E Eigenbrodt; P Jansen-Dürr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 6.  Crosstalk of Notch with p53 and p63 in cancer growth control.

Authors:  G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2009-07-16       Impact factor: 60.716

7.  Human papillomavirus type 16 E7 oncoprotein associates with E2F6.

Authors:  Margaret E McLaughlin-Drubin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

8.  The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice.

Authors:  Regina Pfefferle; Gian Paolo Marcuzzi; Baki Akgül; Hans Udo Kasper; Falko Schulze; Ingo Haase; Claudia Wickenhauser; Herbert Pfister
Journal:  J Invest Dermatol       Date:  2008-04-10       Impact factor: 8.551

9.  Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation.

Authors:  Xiaobo Zhou; Karl Münger
Journal:  Virology       Date:  2009-01-08       Impact factor: 3.616

10.  Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association.

Authors:  Heather L Howie; Jennifer I Koop; Joleen Weese; Kristin Robinson; Greg Wipf; Leslie Kim; Denise A Galloway
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

View more
  54 in total

1.  Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.

Authors:  Ebenezer Tumban; Pavan Muttil; Carolina Andrea A Escobar; Julianne Peabody; Denis Wafula; David S Peabody; Bryce Chackerian
Journal:  Vaccine       Date:  2015-05-21       Impact factor: 3.641

2.  The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation.

Authors:  Jordan M Meyers; Jennifer M Spangle; Karl Munger
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

3.  Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.

Authors:  Guo Peng; Wang Dan; Wu Jun; Yang Junjun; Ren Tong; Zhu Baoli; Xiang Yang
Journal:  Tumour Biol       Date:  2015-01-14

4.  URI expression in cervical cancer cells is associated with higher invasion capacity and resistance to cisplatin.

Authors:  Junxia Gu; Yuting Liang; Longwei Qiao; Yaojuan Lu; Xiaoxia Hu; Dongwei Luo; Na Li; Leilei Zhang; Yiyang Chen; Jialu Du; Qiping Zheng
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

5.  Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Authors:  Aayushi Uberoi; Satoshi Yoshida; Paul F Lambert
Journal:  J Virol Methods       Date:  2017-12-15       Impact factor: 2.014

6.  Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus.

Authors:  Sugandha Saboo; Ebenezer Tumban; Julianne Peabody; Denis Wafula; David S Peabody; Bryce Chackerian; Pavan Muttil
Journal:  Mol Pharm       Date:  2016-04-11       Impact factor: 4.939

7.  Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing.

Authors:  Nathan D Montgomery; Joel S Parker; David A Eberhard; Nirali M Patel; Karen E Weck; Norman E Sharpless; Zhiyuan Hu; David Neil Hayes; Margaret L Gulley
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016-08

Review 8.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

Review 9.  Oncogenic Papillomavirus and Polyomavirus in Water Environments: Is There a Potential for Waterborne Transmission?

Authors:  M Fratini; P Di Bonito; G La Rosa
Journal:  Food Environ Virol       Date:  2013-11-30       Impact factor: 2.778

10.  A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.

Authors:  Ahmed El-Shamy; Francis J Eng; Erin H Doyle; Arielle L Klepper; Xiaochen Sun; Angelo Sangiovanni; Massimo Iavarone; Massimo Colombo; Robert E Schwartz; Yujin Hoshida; Andrea D Branch
Journal:  J Hepatol       Date:  2015-07-26       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.